Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Br J Surg ; 108(9): 1082-1089, 2021 09 27.
Article in English | MEDLINE | ID: mdl-34027968

ABSTRACT

BACKGROUND: Given the susceptibility of organs to ischaemic injury, alternative preservation methods to static cold storage (SCS), such as normothermic machine perfusion (NMP) are emerging. The aim of this study was to perform a comparison between NMP and SCS in liver transplantation with particular attention to bile duct lesions. METHODS: The outcomes of 59 consecutive NMP-preserved donor livers were compared in a 1 : 1 propensity score-matched fashion to SCS control livers. Postoperative complications, patient survival, graft survival and bile duct lesions were analysed. RESULTS: While patients were matched for cold ischaemia time, the total preservation time was significantly longer in the NMP group (21 h versus 7 h, P < 0.001). Patient and graft survival rates at 1 year were 81 versus 82 per cent (P = 0.347) and 81 versus 79 per cent (P = 0.784) in the NMP and SCS groups, respectively. The postoperative complication rate was comparable (P = 0.086); 37 per cent NMP versus 34 per cent SCS patients had a Clavien-Dindo grade IIIb or above complication. There was no difference in early (30 days or less) (NMP 22 versus SCS 19 per cent, P = 0.647) and late (more than 30 days) (NMP 27 versus SCS 36 per cent, P = 0.321) biliary complications. However, NMP-preserved livers developed significantly fewer ischaemic-type bile duct lesions (NMP 3 versus SCS 14 per cent, P = 0.047). CONCLUSION: The use of NMP allowed for a significantly prolonged organ preservation with a lower rate of observed ischaemic-type bile duct lesions.


Subject(s)
Bile Ducts/surgery , Cold Ischemia/instrumentation , Liver Transplantation/methods , Organ Preservation/instrumentation , Perfusion/instrumentation , Tissue Donors , Warm Ischemia/methods , Female , Follow-Up Studies , Graft Survival , Humans , Male , Middle Aged , Propensity Score , Retrospective Studies
2.
Transplant Proc ; 53(2): 624-629, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33139038

ABSTRACT

BACKGROUND: The relationship between nutrition and liver disease is relevant for the outcome after surgery. Patients with liver cirrhosis characteristically show protein-energy malnutrition with decreased levels of branched-chain amino acids (BCAA) and increased levels of aromatic amino acids. MATERIALS AND METHODS: We conducted a prospective controlled clinical trial including 57 patients after liver transplantation or major liver resection surgery in order to test the effect of early postoperative nutrition on the outcome and nutrition profile of these patients. The test group received a dietetic program composed of ingredients naturally rich in BCAA (BCAA group), and the control group received standard hospital meals. Patient survival, liver function tests, subjective well-being, and a nutritional status including amino acid profiles were analyzed immediately and 14 days after major liver surgery (secondary end points). General health and well-being were assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (primary end point). RESULTS: In-depth analysis of amino acid profiles was performed for patients undergoing liver resection (n = 21) and liver transplantation (n = 36). Interestingly, amino acid profiles did not correlate with body mass index or the Model for End-Stage Liver Disease score. Patients scheduled for liver transplantation showed significantly lower levels of BCAA pretransplant compared to patients undergoing liver resection. Patients in the liver resection subgroup were more likely to benefit from the BCAA cuisine in terms of significantly higher food intake and subjective rating. The clinical liver function tests, however, did not show statistical difference between the BCAA group and the control group in the examination period of 14 days. CONCLUSION: Our specifically designed BCAA-enriched diet resulted in greater patient satisfaction and compliance with nutrition. A larger trial or longer-term follow-up may be required to identify an effect on survival, recovery, surgical complications, protein profiles, and amino acid profiles.


Subject(s)
Amino Acids, Branched-Chain/therapeutic use , Liver Diseases/diet therapy , Liver Diseases/surgery , Liver Transplantation , Amino Acids, Branched-Chain/blood , Female , Hepatectomy/methods , Humans , Male , Middle Aged , Nutritional Status , Prospective Studies
3.
Br J Surg ; 105(13): 1816-1824, 2018 12.
Article in English | MEDLINE | ID: mdl-30007018

ABSTRACT

BACKGROUND: Pancreas retransplantation is still a controversial option after loss of a pancreatic graft. This article describes the experience of pancreas retransplantation at a high-volume centre. METHODS: This was a retrospective observational study of all pancreas retransplantations performed in a single centre between 1997 and 2013. Pancreatic graft loss was defined by the return to insulin dependence. Risk factors for graft loss as well as patient and graft survival were analysed using logistic and time-to-event regression models. RESULTS: Of 409 pancreas transplantations undertaken, 52 (12·7 per cent) were identified as pancreas retransplantations. After a median follow-up of 65·0 (range 0·8-174·3) months, 1- and 5-year graft survival rates were 79 and 69 per cent respectively, and 1- and 5-year patient survival rates were 96 and 89 per cent. During the entire follow-up, 22 grafts (42 per cent) were lost. Patient survival was not associated with any of the donor- or recipient-related factors investigated. Five-year graft survival was better after simultaneous kidney-pancreas retransplantation than pancreas retransplantation alone: 80 per cent (16 of 20) versus 63 per cent (20 of 32) (P = 0·226). Acute rejection (odds ratio 4·49, 95 per cent c.i. 1·59 to 12·68; P = 0·005) and early surgical complications (OR 3·29, 1·09 to 9·99, P = 0·035) were identified as factors with an independent negative effect on graft survival. CONCLUSION: Pancreas retransplantation may be considered for patients whose previous graft has failed.


Subject(s)
Graft Rejection/surgery , Pancreas Transplantation/statistics & numerical data , Adult , Antibiotic Prophylaxis , Female , Graft Rejection/mortality , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/mortality , Kidney Transplantation/statistics & numerical data , Male , Middle Aged , Pancreas Transplantation/mortality , Postoperative Care/methods , Reoperation/mortality , Reoperation/statistics & numerical data , Retrospective Studies , Surgical Wound Infection/prevention & control , Tissue Donors/statistics & numerical data , Treatment Outcome , Young Adult
4.
S D J Med ; 42(2): 9, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2711180
5.
S D J Med ; 41(9): 11, 1988 Sep.
Article in English | MEDLINE | ID: mdl-3147513
SELECTION OF CITATIONS
SEARCH DETAIL
...